25 years into research with the Méhes Scale, a comprehensive scale of modern dysmorphology

Dalma Tényi1, Györgyi Csábi2, József Janszky1

  • 1Department of Neurology, Medical School, Clinical Center, University of Pécs, Pécs, Hungary.

Frontiers in Psychiatry
|November 19, 2024
PubMed

Insights

Minor physical anomalies (MPAs) are external markers of abnormal neurodevelopment. Research shows increased MPAs in various neuropsychiatric disorders, suggesting their role in these conditions and as potential trait markers in relatives.

Area of Science:

  • Neurodevelopmental Biology
  • Medical Genetics
  • Psychiatry

Background:

  • Minor physical anomalies (MPAs) are subtle external markers of abnormal neurodevelopment.
  • Previous studies using the Waldrop Scale yielded conflicting results regarding MPAs in neurodevelopmental disorders.
  • A need existed for a comprehensive MPA scale differentiating malformations from variants.

Purpose of the Study:

  • To review 25 years of research utilizing the Méhes Scale to investigate MPAs in neuropsychiatric and neurologic disorders.
  • To summarize findings on the association between MPAs and specific neurodevelopmental conditions.
  • To explore the potential of MPAs as endophenotypic trait markers.

Main Methods:

  • Utilized the 57-item Méhes Scale, which differentiates minor malformations from phenogenetic variants.
  • Conducted research since 1997 on patients with schizophrenia, bipolar disorder, Tourette syndrome, autism, and epilepsy syndromes.
  • Analyzed MPAs in first-degree relatives of patients with schizophrenia and bipolar I disorder.

Main Results:

  • An increased number of MPAs, particularly in the head and mouth regions, were observed in patients with schizophrenia, bipolar disorder, Tourette syndrome, autism, and epilepsy syndromes.
  • Elevated MPAs were also detected in first-degree relatives of patients with schizophrenia and bipolar I disorder.
  • Findings reinforce the link between abnormal neurodevelopment and these disorders.

Conclusions:

  • The Méhes Scale has been instrumental in clarifying the role of MPAs in neurodevelopmental disorders.
  • Increased MPAs in patients and their relatives support the hypothesis of MPAs as endophenotypic trait markers.
  • Abnormal neurodevelopment is significantly implicated in the pathogenesis of various neuropsychiatric conditions.